Diffuse pulmonary parenchymal involvement in multiple myeloma: antemortem diagnosis
Rammurti Kamble1, Thomas Rosenzweig
1Baylor College of Medicine, Cell & Gene Therapy, Houston, Texas 77030, USA. Kamble@sbcglobal.net
International Journal of Hematology
|May 25, 2006
Summary
Diagnosing diffuse myelomatous pulmonary infiltrate antemortem is rare. Bronchoalveolar lavage fluid analysis can identify monoclonal plasma cells, aiding diagnosis of lung involvement in myeloma.
Area of Science:
- Pulmonology
- Hematology
- Oncology
Background:
- Antemortem diagnosis of diffuse myelomatous pulmonary infiltrate is uncommon.
- Pulmonary involvement in multiple myeloma can present as diffuse infiltrates.
- Establishing an early diagnosis is crucial for patient management.
Observation:
- A rare case of diffuse myelomatous pulmonary infiltrate diagnosed antemortem is presented.
- Diagnosis was achieved through analysis of bronchoalveolar lavage (BAL) fluid.
- BAL fluid revealed the presence of monoclonal plasma cells.
Findings:
- The diffuse lung involvement by myeloma was confirmed post-mortem.
- Clinical indicators included lack of fever, poor response to antibiotics, and improvement with myeloma treatment.
- Analysis of BAL fluid for plasma cells and cytoplasmic immunoglobulin DNA offers a noninvasive diagnostic method.
Implications:
- Myelomatous pulmonary infiltrates should be considered in the differential diagnosis of pulmonary infiltrates.
- Noninvasive methods like BAL fluid analysis can facilitate early diagnosis.
- Timely diagnosis and treatment of pulmonary involvement in myeloma can improve patient outcomes.

